# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001437749-18-005833
Filing Date
2018-03-29
Accepted
2018-03-29 16:18:40
Documents
15
Period of Report
2018-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | kmph20180326_8k.htm | 8-K | 25173
2 | EXHIBIT 99.1 | ex_109019.htm | EX-99.1 | 174897
3 | EXHIBIT 99.2 | ex_109020.htm | EX-99.2 | 6212
4 |  | slide10.jpg | GRAPHIC | 92852
5 |  | slide09.jpg | GRAPHIC | 181039
6 |  | slide08.jpg | GRAPHIC | 186907
7 |  | slide07.jpg | GRAPHIC | 326748
8 |  | slide06.jpg | GRAPHIC | 243029
9 |  | slide05.jpg | GRAPHIC | 347294
10 |  | slide04.jpg | GRAPHIC | 361176
11 |  | slide03.jpg | GRAPHIC | 111367
12 |  | slide02.jpg | GRAPHIC | 461263
13 |  | slide01.jpg | GRAPHIC | 92852
14 |  | ex99-1img002.jpg | GRAPHIC | 3740
15 |  | ex99-1img001.jpg | GRAPHIC | 2054
| Complete submission text file | 0001437749-18-005833.txt |  | 3518528

Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 18723188
SIC: 2834 Pharmaceutical Preparations